Merck Serono International SA
Merck Serono International SA describe recent developments
Published in Healthcare Finance, Tax and Law Weekly, July 18th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Merck Serono International SA.
Report 1: Merck Serono S.A. (virt-x: SEO) announced that Phase III data on safinamide, a new agent in Phase III development for the treatment of Parkinson's disease symptoms, were presented by Professor Fabrizio Stocchi at the American Academy of Neurology 59th Annual Meeting in Boston, Massachusetts, USA. These data are from a 6-month (24 weeks), randomized, double blind, placebo-controlled, international trial.
"These data are promising...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals Appoints Pharmaceutical and Medical Device Veteran to Board of Directors - Aging
Budget Impasse Requires PA Department of Aging to Furlough Half of its Workforce - Aging
Ed Koch, Bob Weiner Urge Home Care Alternatives to Nursing Homes; Seek Congress Address 'Silent Sadness of Seniors' Forced Unnecessarily to Leave Own Homes - Allscripts
Troy Moritz Joins Allscripts as Chief Security Officer - Alzheimer Disease
Scientists at Chang-Gung University publish new data on Alzheimer disease - Angiology
Judge Grants Diomed Permanent Injunction in '777 Patent Case - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
